Grail (NASDAQ:GRAL) Stock Price Down 4.4% – Should You Sell?

Grail, Inc. (NASDAQ:GRAL)’s share price fell 4.4% on Thursday . The stock traded as low as $16.78 and last traded at $16.80. 206,992 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 640,543 shares. The stock had previously closed at $17.58.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Morgan Stanley started coverage on shares of Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company. Guggenheim started coverage on shares of Grail in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock. Finally, Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company.

Grail Stock Performance

The company’s 50 day simple moving average is $18.21.

Insider Activity at Grail

In related news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Institutional Investors Weigh In On Grail

Several large investors have recently modified their holdings of the business. Douglas Lane & Associates LLC acquired a new stake in Grail during the 4th quarter worth approximately $3,034,000. 180 Wealth Advisors LLC acquired a new stake in shares of Grail during the fourth quarter worth $1,681,000. A. D. Beadell Investment Counsel Inc. bought a new stake in Grail in the 4th quarter valued at $430,000. B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail in the 4th quarter worth $387,000. Finally, FNY Investment Advisers LLC bought a new position in Grail during the 4th quarter worth about $26,000.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.